Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricDGXQuest DiagnosticsLHLabcorpDVADaVita
Snapshot
Price$193.58$254.43$209.68
Market cap$21.59B$20.98B$13.35B
Valuation
P/E21x22.3x17.1x
Forward P/E18.3x17.2x16x
Growth
Revenue growth11.0%7.3%6.7%
EPS growth14.9%30.2%6.6%
Profitability
Net margin9.1%6.7%5.7%
ROE14.1%10.9%181.2%
Balance sheet & cash
Debt / equity0.82x0.66x77.99x
Free cash flow yield5.4%5.2%8.2%
Dividend yield1.7%1.1%—
Verdict
Investment ratingNeutral· 57Favorable· 58Neutral· 53

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearDGXtoday $194LHtoday $254DVAtoday $210
2027$166.79 – $244.62+26% CAGR$248.37 – $364.28+43% CAGR$167.65 – $245.89+17% CAGR
2028$191.61 – $281.02+20% CAGR$323.28 – $474.15+37% CAGR$178.74 – $262.15+12% CAGR
2029$220.12 – $322.84+19% CAGR$420.79 – $617.15+34% CAGR$190.55 – $279.48+10% CAGR
2030$252.87 – $370.88+18% CAGR$547.70 – $803.29+33% CAGR$203.15 – $297.95+9% CAGR
2031$290.50 – $426.06+17% CAGR$712.88 – $1,045.56+33% CAGR$216.57 – $317.64+9% CAGR
5-yr CAGR8.5% – 17.1%22.9% – 32.7%0.6% – 8.7%